5-12 However, in clinical trials, including SURMOUNT-1 for tirzepatide and STEP 1 for semaglutide, participants were permitted to remain on a given dose for up to 4 additional weeks, as needed, to allow for the dissipation of any GI AEs
[DOI] [PMC free article] [PubMed] [Google Scholar] 168.Yoshino J., Baur J.A., Imai S.I
Regionally, Asia-Pacific Led the GLP-1 Market
Whilst the heart rate increases observed were statistically significant, they were not associated with a higher rate of serious adverse cardiac events in the Phase 2 data
All products are sold as reference standards and research chemicals only.
Yet changing dietary habits is crucial on these powerful drugs, especially since data shows that about half of people quit within a year, then rapidly regain weight